AFib, short for atrial fibrillation, is a heart rhythm disorder where the upper chambers of the heart (the atria) beat chaotically and out of sync with the lower chambers. It affects roughly 52.5 million people worldwide and is the most common type of irregular heartbeat. While some people feel nothing at all, AFib raises the risk of stroke and heart failure, making it a condition worth understanding even when symptoms seem mild.
What Happens Inside the Heart
In a healthy heart, a small cluster of cells called the sinus node sends a steady electrical signal that travels through the atria, telling them when to contract. This keeps the heartbeat organized: the atria squeeze first, pushing blood into the lower chambers (ventricles), which then pump it out to the body.
In AFib, that orderly process breaks down. Instead of one clean signal, dozens of disorganized electrical impulses fire across the atria at the same time. The atria don’t contract in a coordinated way. They quiver or fibrillate, like a bag of worms rather than a squeezing fist. Only some of those chaotic signals reach the ventricles, which is why the resulting heartbeat feels fast, slow, or wildly irregular from one beat to the next.
Two things drive this electrical chaos. First, cells in the atria can start firing on their own when they shouldn’t, generating rogue electrical impulses. Second, those impulses can loop back on themselves in circular patterns called reentry circuits. The shorter these loops are, the more of them can exist simultaneously, and the harder AFib becomes to stop. Over time, AFib itself remodels the heart’s electrical wiring and tissue, creating scarring and inflammation that make future episodes more likely. This is why cardiologists often say “AFib begets AFib.”
Types of AFib
AFib is classified by how long episodes last and how they respond to treatment:
- Paroxysmal AFib comes and goes, with episodes lasting less than seven days. The heart returns to its normal rhythm on its own.
- Persistent AFib lasts at least seven consecutive days and typically requires medical intervention to restore a normal rhythm.
- Permanent AFib does not improve with treatment, and the decision is made to stop trying to restore normal rhythm.
These categories aren’t always rigid. Many people start with occasional paroxysmal episodes that gradually become more frequent and longer-lasting, eventually progressing to persistent or permanent AFib.
Common Symptoms
The hallmark symptom is a fast, fluttering, or pounding heartbeat, often described as the heart “flopping” or “racing” in the chest. Other common symptoms include shortness of breath, fatigue, dizziness, lightheadedness, chest pain, weakness, and a reduced ability to exercise. These can range from barely noticeable to debilitating.
Some people with AFib don’t notice any symptoms at all. Their condition is discovered incidentally during a routine checkup or when they develop a complication like a stroke. This “silent” AFib is one reason the condition can be dangerous: the stroke risk exists whether or not you feel anything wrong.
Why AFib Raises Stroke Risk
When the atria quiver instead of contracting fully, blood pools and moves sluggishly through them. This pooling allows clots to form, particularly in a small pouch called the left atrial appendage. If a clot breaks free, it can travel to the brain and block an artery, causing a stroke.
The amount of time spent in AFib matters. Research on patients with implanted heart monitors found that those spending less than one hour in AFib during follow-up actually had higher stroke rates than those with longer episodes, likely because other risk factors were at play. This highlights that stroke risk in AFib depends on more than just the rhythm itself. It involves a combination of age, blood pressure, diabetes, prior strokes, and other vascular conditions.
Measuring Your Stroke Risk
Doctors use a scoring tool called CHA2DS2-VASc to estimate how likely a person with AFib is to have a stroke. It assigns points based on specific risk factors:
- Heart failure: 1 point
- High blood pressure: 1 point
- Age 75 or older: 2 points
- Diabetes: 1 point
- Prior stroke or mini-stroke: 2 points
- Vascular disease (prior heart attack or artery disease): 1 point
- Age 65 to 74: 1 point
- Female sex: 1 point
Scores range from 0 to 9. Higher scores mean greater stroke risk and a stronger case for blood-thinning medication. A score of 0 in men or 1 in women generally suggests low risk, while a score of 2 or higher typically leads to a recommendation for anticoagulation therapy.
How AFib Leads to Heart Failure
Beyond stroke, AFib can weaken the heart muscle over time through several mechanisms. When the ventricles beat too fast for too long, the heart muscle becomes exhausted, a condition called arrhythmia-induced cardiomyopathy. The heart chambers stretch and dilate, and the pumping ability drops.
AFib also eliminates the “atrial kick,” the final push of blood from the atria into the ventricles that accounts for roughly 20 to 30 percent of the heart’s filling. Losing this contribution reduces how much blood the heart pumps with each beat. Add in the irregular timing between beats, which prevents the ventricles from filling efficiently, and the combined effect can tip someone into heart failure. The encouraging news is that arrhythmia-induced cardiomyopathy is often reversible once a normal rhythm is restored.
How AFib Is Diagnosed
An electrocardiogram (ECG or EKG) is the standard diagnostic test. In AFib, the ECG shows a distinctive pattern: the rhythm is “irregularly irregular,” meaning there’s no predictable spacing between heartbeats. The normal P-waves, small bumps that represent organized atrial contraction, are completely absent. Instead, the baseline looks chaotic, with fine or coarse fibrillatory waves replacing the smooth line between beats. These fibrillatory waves can sometimes mimic P-waves, which occasionally leads to misdiagnosis.
If episodes come and go, a standard ECG might miss them. In that case, you may wear a portable heart monitor for 24 hours to several weeks, or use a smartwatch with ECG capability, to catch intermittent episodes.
Treatment: Rate Control vs. Rhythm Control
Treatment for AFib rests on three pillars: preventing stroke (usually with blood thinners), controlling the heart rate, and deciding whether to try restoring a normal rhythm.
Rate control means accepting that AFib will continue but using medication to keep the heart from beating too fast. The goal is a comfortable resting heart rate, typically under 110 beats per minute, so the heart can still function well even though its rhythm is irregular. This approach tends to be simpler and works well for many older patients with few symptoms.
Rhythm control means actively trying to restore and maintain a normal heartbeat. This can involve medications that suppress abnormal electrical activity, electrical cardioversion (a brief procedure that resets the heart’s rhythm with a controlled shock), or catheter ablation. In catheter ablation, a thin tube is threaded into the heart to destroy the small areas of tissue generating the rogue electrical signals. The procedure is most effective for paroxysmal AFib, though recurrence rates after a single ablation remain high, between 35 and 50 percent, especially for persistent AFib. Many people need a second procedure.
For decades, large trials suggested rate and rhythm control produced similar outcomes. But more recent research has shifted the balance. A major trial found that early rhythm control, started soon after diagnosis, reduced cardiovascular complications compared to the older approach of trying rate control first. Rhythm control is now generally preferred for people under 70 and those with heart failure.
Who Gets AFib
AFib is overwhelmingly a condition of aging. The risk climbs steeply after age 65, and the global burden is concentrated in higher-income regions where populations tend to be older. In 2021, Western Europe recorded about 600,000 new cases, while high-income regions collectively accounted for over 17 million prevalent cases. East Asia had the highest regional burden at 11.2 million cases, driven largely by its massive population.
Global cases are projected to keep rising through 2050 as populations age, though death rates from AFib are expected to decline as treatments improve. Risk factors you can influence include high blood pressure (the single biggest modifiable risk factor), obesity, heavy alcohol use, sleep apnea, and lack of physical activity. Thyroid disease, heart valve problems, and a family history of AFib also raise risk.